GoodRx Holdings (GDRX) Deferred Taxes (2019 - 2026)
GoodRx Holdings' Deferred Taxes history spans 7 years, with the latest figure at $12.0 million for Q4 2025.
- On a quarterly basis, Deferred Taxes rose 206.3% to $12.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $68000.0, a 100.57% increase, with the full-year FY2025 number at $20.1 million, up 268.47% from a year prior.
- Deferred Taxes hit $12.0 million in Q4 2025 for GoodRx Holdings, up from -$11.3 million in the prior quarter.
- Over the last five years, Deferred Taxes for GDRX hit a ceiling of $46.1 million in Q4 2021 and a floor of -$63.0 million in Q2 2023.
- Historically, Deferred Taxes has averaged -$3.5 million across 5 years, with a median of -$227000.0 in 2021.
- The widest YoY moves for Deferred Taxes: up 2459.49% in 2023, down 108746.55% in 2023.
- Tracing GDRX's Deferred Taxes over 5 years: stood at $46.1 million in 2021, then plummeted by 100.77% to -$356000.0 in 2022, then tumbled by 2027.25% to -$7.6 million in 2023, then tumbled by 48.84% to -$11.3 million in 2024, then skyrocketed by 206.3% to $12.0 million in 2025.
- Business Quant data shows Deferred Taxes for GDRX at $12.0 million in Q4 2025, -$11.3 million in Q4 2024, and -$642000.0 in Q3 2024.